Changeflow GovPing Consumer Protection NSQ Drug Alerts - Not Standard Quality Pharmace...
Priority review Notice Added Final

NSQ Drug Alerts - Not Standard Quality Pharmaceuticals India

Favicon for cdsco.gov.in CDSCO India Alerts
Detected
Email

Summary

CDSCO India publishes Not Standard Quality (NSQ) drug alerts listing pharmaceutical products found non-compliant with quality standards during testing. Alert records identify affected drug products, recalling manufacturers, specific quality defects, and test failure parameters. Alert dates and product identifiers are recorded for each entry to facilitate regulatory traceability and market withdrawal actions by state drug authorities and healthcare providers.

Published by CDSCO on cdsco.gov.in . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors CDSCO India Alerts for new consumer protection regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 1 changes logged to date.

What changed

CDSCO India NSQ Drug Alerts compilation publishes drug products found not of standard quality during regulatory testing. Each alert record documents the drug name, manufacturer or supplier name, nature of quality defect, and test failure parameters such as assay failure or particulate matter contamination. The alerts serve as public notification mechanisms enabling state drug controllers, healthcare providers, and supply chain stakeholders to identify and remove non-compliant products from circulation.

Pharmaceutical manufacturers and drug suppliers should monitor CDSCO NSQ alert publications to track quality defect trends across product categories and counterparties. Healthcare providers and procurement teams should cross-reference supplied drug batches against published NSQ records to identify affected stock. State drug authorities may initiate market withdrawal actions based on CDSCO NSQ alert notifications.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Get daily alerts for CDSCO India Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from CDSCO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
CDSCO
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug quality testing Product safety alerts Market withdrawal
Geographic scope
IN IN

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health Healthcare

Get alerts for this source

We'll email you when CDSCO India Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!